Gaps in Prenatal Syphilis Screening Threaten Infant Health in Ontario: New Study Reveals Stark Inequities
In a country with universal healthcare and advanced medical infrastructure, congenital syphilis—a preventable and treatable condition—should be virtually eradicated. However, recent research conducted by ICES and Queen’s University, backed by the Canadian Institutes of Health Research, has uncovered alarming gaps in prenatal syphilis screening that put countless infants at risk across Ontario. The investigation, published in the Canadian Medical Association Journal in May 2026, reveals that one in five pregnancies do not receive syphilis screening within the critical first trimester, a timeframe essential to preventing irreversible damage to both fetus and mother.
The study meticulously analyzed health records from over half a million pregnancies—551,706 in total—spanning nearly six years from January 2018 to December 2023. Out of these pregnancies, 507,169 underwent syphilis screening at some point, but only 435,162 were screened early in the first trimester. Approximately three percent of screened pregnancies did not receive testing until the third trimester or even at delivery, significantly diminishing the opportunity for timely intervention. This delay poses a serious public health challenge because developmental damage caused by syphilis in utero can be catastrophic, leading to stillbirth, neonatal death, or severe lifelong disabilities.
Of particular concern is that late or absent screening disproportionately affects equity-deserving populations. These groups frequently face multifaceted barriers within the healthcare system, including socioeconomic disadvantage, geographic isolation, systemic discrimination, and limited access to culturally sensitive care providers. The researchers emphasize that current prenatal care models may be insufficiently adaptive to reach such communities, underscoring an urgent need to overhaul screening delivery methods to close persistent health inequities.
The epidemiology of syphilis among women in Canada is shifting alarmingly. National surveillance data from 2023 indicates a congenital syphilis rate of 14.5 cases per 100,000 live births—a stunning 220 percent increase since 2018. This resurgence is a clear indicator that infectious syphilis among pregnant women is on the rise, fueling congenital transmission and challenging the assumption that modern health systems can contain such infections unilaterally. Given the grave consequences of untreated congenital syphilis, including miscarriage, preterm birth, and neonatal mortality, this trend is nothing short of a public health emergency.
Dr. Sahar Saeed, Assistant Professor in the Department of Public Health Sciences at Queen’s University and senior author of the study, poignantly remarks, “Congenital syphilis should not be happening in a high-income country with universal healthcare.” She adds, “The fact that one in five pregnancies is not screened on time signals profound systemic inequities and retrieval failures in our current healthcare delivery structures.” This statement not only highlights clinical shortcomings but shines a spotlight on the socio-political context surrounding healthcare access in Ontario and Canada.
The investigative team advocates for radical innovation in prenatal screening protocols. Amanda Featherstone, the study’s lead author, argues that “we cannot rely solely on traditional prenatal care models.” She stresses the importance of implementing complementary screening strategies, such as opportunistic testing during unrelated care visits, community outreach programs, and point-of-care rapid tests delivered outside standard clinical settings. These approaches are designed to be non-judgmental and culturally competent, breaking down trust barriers that often prevent marginalized groups from seeking timely prenatal care.
Evidence from pilot programs supporting community-based interventions reveals promising outcomes. For example, mobile clinics staffed with culturally trained healthcare workers and equipped with rapid syphilis test kits have demonstrated increased screening uptake in under-served areas. By bringing testing services directly into communities, these programs minimize logistical challenges, reduce stigma, and allow for immediate treatment initiation when positive cases are identified. Such initiatives present a compelling case for health authorities to adopt multi-pronged strategies tailored to the diverse needs of pregnant individuals.
The consequences of failing to address these gaps are profound. Congenital syphilis is associated with a range of severe neonatal outcomes, including neurologic impairment, bone deformities, and blindness, as well as fetal demise. The disease is uniquely preventable when timely screening and treatment protocols are implemented, making these ongoing disparities all the more troubling. Moreover, untreated maternal syphilis poses health risks to the mother herself, including increased susceptibility to co-infection with other sexually transmitted infections.
This research utilized a population-based retrospective cohort design, drawing on comprehensive health data from administrative databases spanning six years. By leveraging such large-scale, high-quality datasets, the study offers robust epidemiological insights into prenatal screening patterns across Ontario, identifying systemic failings in coverage and timing with a high degree of precision. The observational nature of the research precludes establishing causality but elucidates critical associations between sociodemographic factors and delays in screening uptake.
The findings demand immediate policy action. Public health authorities, practitioners, and community stakeholders must collaborate to redesign prenatal care pathways, integrating equity-focused approaches that emphasize accessibility, cultural safety, and proactive outreach. Training providers in equity-based care, expanding the availability of rapid diagnostic tools, and prioritizing funding for community-driven programs could collectively reverse current trends and safeguard newborn health.
Enhanced surveillance mechanisms are also vital to monitor congenital syphilis rates in real time and evaluate the impact of interventions. Data transparency and engagement with affected communities will ensure that strategies remain responsive and effective. Without swift and coordinated efforts, Ontario risks a further acceleration in congenital syphilis rates, imperiling the health of future generations in a country capable of delivering comprehensive prenatal care.
In conclusion, this groundbreaking study provides compelling, data-backed evidence that critical gaps in prenatal syphilis screening exist in Ontario, with late and missed tests disproportionately affecting marginalized populations. The resurgence of congenital syphilis signals an urgent call to action to rethink, redesign, and expand prenatal screening programs, ensuring all pregnant individuals receive timely and equitable care. Failure to do so threatens not only individual families but broader public health gains achieved over decades. This is a pivotal moment demanding bold innovation and unwavering commitment to health equity in prenatal care.
Subject of Research: People
Article Title: Uptake of prenatal syphilis screening and its determinants in Ontario, Canada: a population-based retrospective cohort study
News Publication Date: 19-May-2026
Web References:
http://dx.doi.org/10.1503/cmaj.251757
References:
Uptake of prenatal syphilis screening and its determinants in Ontario, Canada: a population-based retrospective cohort study. Canadian Medical Association Journal, May 2026.
Keywords: Prenatal screening, Syphilis, Congenital syphilis, Infectious diseases, Public health, Health equity, Prenatal care, Ontario, Maternal health, Screening uptake, Epidemiology, Point-of-care testing
